全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1427409-40-2 | 4-Bromo-2-fluoro-6-methylbenzoic acid methyl ester;Methyl 4-bromo-2-fluoro-6-methylbenzoate | C9H8BrFO2 |
| 1427415-25-5 | Methyl 4-bromo-2-fluoro-6-methoxybenzoate | C9H8BrFO3 |
| 1427420-85-6 | 7-Chloro-5-benzofurancarbonitrile | C9H4ClNO |
| 1427429-75-1 | 2-(Bromomethyl)-3-fluoropyridine hydrobromide (1:1) | C6H5BrFN.HBr |
| 1427439-32-4 | 4-Bromo-2-chloro-3-fluorobenzonitrile | C7H2BrClFN |
| 1427446-97-6 | 5-Fluorobenzofuran-4-carbonitrile;5-fluoro-1-benzofuran-4-carbonitrile | C9H4FNO |
| 1427460-49-8 | Ethyl 3-(2-oxoimidazolidin-1-yl)benzoate | C12H14N2O3 |
| 1427460-96-5 | 7-Bromo-1H-indazole-5-carboxylic acid methyl ester | C9H7BrN2O2 |
| 1427475-12-4 | 5-Bromo-1H-1,2,4-triazole-3-carbonitrile | C3HBrN4 |
| 1427475-33-9 | 1,4-Dimethyl-1H-imidazol-5-amine hydrochloride | C5H9N3.HCl |
| 1427521-38-7 | JWH-250 4-Hydroxypentyl | C22H25NO3 |
| 1427587-32-3 | 1-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-2(1H)-one | C16H22BNO3 |
| 1427701-11-8 | 6-Bromo-2-fluoro-3-(trifluoromethyl)pyridine | C6H2BrF4N |
| 1427782-89-5 | N-(5-Phenyl-2-pyridinyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]acetamide | C25H20N4O2S2 |
| 1428243-26-8 | (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester;benzyl (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate | C16H20BrNO3 |
| 1428243-36-0 | (3R,4S)-1-((Benzyloxy)carbonyl)-4-methylpyrrolidine-3-carboxylic acid | C14H17NO4 |
| 1428243-71-3 | (3S,4R)-1-((Benzyloxy)carbonyl)-4-methylpyrrolidine-3-carboxylic acid | C14H17NO4 |
| 1428341-13-2 | (3R,4R)-rel-4-Amino-3-methyl-1-piperidinecarboxylic acid 1,1-dimethylethyl ester | C11H22N2O2 |
| 1428450-95-6 | Isobutylamido thiazolyl resorcinol;N-[4-(2,4-dihydroxyphenyl)-1,3-thiazol-2-yl]-2-methylpropanamide | C13H14N2O3S |
| 1428551-28-3 | 9-[1,1'-Biphenyl]-3-yl-3-bromo-9H-carbazole | C24H16BrN |
| 1428940-11-7 | 1-Bromo-3-(bromomethyl)-2-(trifluoromethyl)benzene | C8H5Br2F3 |
| 1428946-52-4 | Methylene Calcitriol ;(1R,3R,Z)-5-(2-((1R,3aS,7aR,E)-1-((R)-6-Hydroxy-6-methylheptan-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-2,4-dimethylenecyclohexane-1,3-diol | C28H44O3 |
| 1429056-28-9 | 2-Oxa-7-azaspiro[3.5]nonane hemioxalate | C16H28N2O6 |
| 1429071-63-5 | Ebastine EP Impurity F;Ebastine N-Oxide;4-(4-benzhydryloxy-1-oxidopiperidin-1-ium-1-yl)-1-(4-tert-butylphenyl)butan-1-one | C32H39NO3 |
| 1429071-65-7 | Ebastine EP Impurity G;1-[4-(1,1-Dimethylethyl)phenyl]-4-[trans-4-(diphenylmethoxy)-1-oxidopiperidin-1-yl]butan-1-one | C32H39NO3 |
| 1429192-00-6 | 2,3-Dihydro-2-(5-methyl-2-thienyl)-3-phenyl-4(1H)-quinazolinone | C19H16N2OS |
| 1429334-00-8 | N-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]acetamide | C16H19N3O5 |
| 1429515-59-2 | N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-4-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1H-pyrazole-5-carboxamide | C22H25N9O |
| 1429636-72-5 | Doxofylline Impurity 6;7-(2,2-Dimethoxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | C11H16N4O4 |
| 1429639-50-8 | N-[4-[5,7-Dihydro-7,7-dimethyl-4-[(3S)-3-methyl-4-morpholinyl]-6,6-dioxidothieno[3,4-d]pyrimidin-2-yl]phenyl]-N'-ethylurea | C22H29N5O4S |
| 1429651-50-2 | 4-[(Hydroxyamino)carbonyl]-N-(2-hydroxyethyl)-N-phenylbenzeneacetamide;HPOB | C17H18N2O4 |
| 1429654-95-4 | 4-Bromo-3,4-dihydro-1H-2-benzopyran-1-one | C9H7BrO2 |
| 1429749-41-6 | N-[(1S)-1-[(Phenylamino)carbonyl]-5-[(1-thioxotetradecyl)amino]pentyl]carbamic acid phenylmethyl ester | C34H51N3O3S |
| 1429850-43-0 | N1-Acetyl Triethylenetetramine Trihydrochloride;N-[2-[[2-[(2-Aminoethyl)amino]ethyl]amino]ethyl]acetamide Trihydrochloride | C8H23Cl3N4O |
| 1429881-91-3 | trans-4-[2-(Butylamino)-5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexanol;UNC 2025 | C28H40N6O |
| 1429908-35-9 | 1-[2-[(2,4-Dimethylphenyl)sulfinyl]phenyl]piperazine | C18H22N2OS |
| 1430089-64-7 | N2-[4-[(3-Aminopropyl)amino]phenyl]-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine | C19H24N8 |
| 1430106-55-0 | (2S)-4-Methyl-1,2-pyrrolidinedicarboxylic acid 1-(1,1-dimethylethyl) 2-methyl ester | C12H21NO4 |
| 1430213-30-1 | N-[4-Fluoro-3-(trifluoromethyl)phenyl]-N'-[5-(4-pyridinyl)-1,3,4-thiadiazol-2-yl]urea | C15H9F4N5OS |
| 1430219-76-3 | Trifluoro(oxetan-3-yl)-lambda4-borane potassium | C3H5BF3O.K |
| 1430270-34-0 | (T-4)-Trifluoro-3-oxetanyl borate | C3H5BF3O |
| 1430844-80-6 | 6-[8-[(2-Benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-3-[5-methyl-1-(tricyclo[3.3.1.1(3,7)]dec-1-ylmethyl)-1H-pyrazol-4-yl]-2-pyridinecarboxylic acid | C38H38N6O3S |
| 1430845-70-7 | 1-(Adamantan-1-ylmethyl)-5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;1-(1-adamantylmethyl)-5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole | C21H33BN2O2 |
| 1431326-61-2 | rel-N1-[(1R,2S)-2-Phenylcyclopropyl]-1,4-cyclohexanediamine hydrochloride (1:2) | C15H22N2.2(HCl) |
| 1431329-58-6 | 4-Chloro-3,5-difluorobenzenemethanol | C7H5ClF2O |
| 1431468-36-8 | Cabozantinib Impurity 5;N,N'-Bis(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | C17H14F2N2O2 |
| 1431525-23-3 | N-[2-Methyl-5-[9-[4-[(methylsulfonyl)amino]phenyl]-2-oxobenzo[h]-1,6-naphthyridin-1(2H)-yl]phenyl]-2-propenamide;BMX-IN-1 | C29H24N4O4S |
| 1431612-23-5 | N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[6-[4-(1-methylethyl)-1-piperazinyl]-3-pyridinyl]-1H-indazole-4-carboxamide | C33H43N7O2 |
| 1431697-85-6 | 4-[(2,6-Dichlorobenzoyl)amino]-N-4-piperidinyl-1H-pyrazole-3-carboxamide 2,2,2-trifluoroacetate | C16H17Cl2N5O2.C2HF3O2 |
| 1431697-89-0 | 1-[6-(3,5-Dichloro-4-hydroxyphenyl)-4-[[trans-4-[(dimethylamino)methyl]cyclohexyl]amino]-1,5-naphthyridin-3-yl]-ethanone | C25H28Cl2N4O2 |